Stromal biology and therapy in pancreatic cancer: a changing paradigm

Albrecht Neeße(Universitätsklinikum Gießen und Marburg), Thomas M. Gress(Universitätsklinikum Gießen und Marburg)
Gut
May 20, 2015
10.1136/gutjnl-2015-309304
Cited by 542

Related Papers

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
|Gut|2019|620
Chronic pancreatitis
|Nature Reviews Disease Primers|2017|447
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis
|Nature Genetics|2006|250
SPARC independent drug delivery and antitumour effects of <i>nab</i> -paclitaxel in genetically engineered mice
|Gut|2013|136
ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer
|Gastroenterology|2016|62